BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33814500)

  • 1. BCR/ABL1-positive B-lymphoblastic Lymphoma Successfully Treated with Dasatinib-combined Chemotherapy.
    Yamada C; Shimomura Y; Kamijyo K; Kanda-Kato M; Yoshioka S; Yamashita D; Ishikawa T
    Intern Med; 2021 Oct; 60(19):3149-3153. PubMed ID: 33814500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
    Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
    Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
    Rousselot P; Coudé MM; Gokbuget N; Gambacorti Passerini C; Hayette S; Cayuela JM; Huguet F; Leguay T; Chevallier P; Salanoubat C; Bonmati C; Alexis M; Hunault M; Glaisner S; Agape P; Berthou C; Jourdan E; Fernandes J; Sutton L; Banos A; Reman O; Lioure B; Thomas X; Ifrah N; Lafage-Pochitaloff M; Bornand A; Morisset L; Robin V; Pfeifer H; Delannoy A; Ribera J; Bassan R; Delord M; Hoelzer D; Dombret H; Ottmann OG;
    Blood; 2016 Aug; 128(6):774-82. PubMed ID: 27121472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.
    Uemura S; Nishimura N; Hasegawa D; Shono A; Sakaguchi K; Matsumoto H; Nakamachi Y; Saegusa J; Yokoi T; Tahara T; Tamura A; Yamamoto N; Saito A; Kozaki A; Kishimoto K; Ishida T; Nino N; Takafuji S; Mori T; Iijima K; Kosaka Y
    Int J Hematol; 2018 May; 107(5):604-609. PubMed ID: 29177615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
    Tan KW; Zhu YY; Qiu QC; Wang M; Shen HJ; Huang SM; Cao HY; Wan CL; Li YY; Dai HP; Xue SL
    Ann Hematol; 2023 Sep; 102(9):2397-2402. PubMed ID: 37103615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.
    Li X; Cao W; Zhang S; Li L; Li Y; Jiang Z; Wan D; Yu J
    Medicine (Baltimore); 2021 Jun; 100(23):e26323. PubMed ID: 34115047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3
    Massimino M; Stella S; Tirrò E; Consoli ML; Pennisi MS; Puma A; Vitale SR; Romano C; Zammit V; Stagno F; DI Raimondo F; Manzella L
    Anticancer Res; 2019 Jul; 39(7):3949-3954. PubMed ID: 31262926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
    De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
    BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
    Ting S; Mixue X; Lixia Z; Xueying L; Wanzhuo X; Xiujin Y
    Ann Hematol; 2020 Apr; 99(4):829-834. PubMed ID: 32107574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript.
    Mroczkowska A; Jaźwiec B; Urbańska-Rakus J; Szymanowska S; Tessmann A; Pająk S; Machnik K; Haus O; Wróbel T
    BMC Med Genomics; 2022 Feb; 15(1):20. PubMed ID: 35123463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Testicular and Cutaneous Philadelphia Chromosome Positive B-Cell Lymphoblastic Lymphoma: A Rare Case and Review.
    Yu Q; Wang G; Wang J; Zhang W; Meng L; Cao Y
    Cancer Manag Res; 2022; 14():1507-1514. PubMed ID: 35478711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations in the BCR-ABL1 gene in a peruvian patient with acute lymphoblastic leukemia resistant to therapy].
    Ortiz CA; Alvarez YP; Dongo-Pflucker KL; Valdivia E; Mendoza Fernández J; Dávila S; Mora-Alférez P
    Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(2):162-166. PubMed ID: 28657534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
    Brattås MK; Reikvam H; Tvedt THA; Bruserud Ø
    Expert Opin Investig Drugs; 2019 May; 28(5):411-420. PubMed ID: 30916583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo RNAi screening identifies
    Fiedler ERC; Bhutkar A; Lawler E; Besada R; Hemann MT
    Blood Adv; 2018 Jun; 2(11):1229-1242. PubMed ID: 29853524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A near-haploid clone harboring a BCR/ABL1 gene fusion in an adult patient with newly diagnosed B-lymphoblastic leukemia.
    Peterson JF; Ketterling RP; Huang L; Finn LE; Shi M; Hoppman NL; Greipp PT; Baughn LB
    Genes Chromosomes Cancer; 2019 Sep; 58(9):665-668. PubMed ID: 30790375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.
    Kawajiri C; Tanaka H; Hashimoto S; Takeda Y; Sakai S; Takagi T; Takeuchi M; Ohwada C; Sakaida E; Shimizu N; Nakaseko C
    Int J Hematol; 2014 Apr; 99(4):513-8. PubMed ID: 24532437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
    Boer JM; den Boer ML
    Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment.
    Yeung DT; Moulton DJ; Heatley SL; Nievergall E; Dang P; Braley J; Branford S; Moore S; Mullighan CG; Hughes TP; White DL
    Leukemia; 2015 Jan; 29(1):230-2. PubMed ID: 25179732
    [No Abstract]   [Full Text] [Related]  

  • 19. Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
    Ahmed IO; Ochogwu LO; Owojuyigbe TO; Akinola NO; Durosinmi MA
    J Med Case Rep; 2021 Oct; 15(1):504. PubMed ID: 34625105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
    Kurita D; Hatta Y; Hojo A; Kura Y; Sawada U; Kanda Y; Takei M
    Cancer Genet; 2016 Apr; 209(4):161-5. PubMed ID: 26854094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.